X

Trial Profile

Effect of Vascepa on Progression of Coronary Atherosclerosis in Persons With Elevated Triglycerides (200-499) on Statin Therapy

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 17 May 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ethyl eicosapentaenoic acid (Primary)
Indications Hypertriglyceridaemia
Focus Therapeutic Use
Acronyms EVAPORATE

Most Recent Events

12 May 2023 Results presented in the Amarin media release.
12 May 2023 According to the Amarin media release, data from this study was presented at the American Heart Association's Vascular Discovery 2023 meeting in Boston, MA, May 10-13.
17 May 2021 According to an Amarin Corporation media release, the company will Webcast Discussion of Data Presented at ACC.21

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com